Cancer Patients Alliance
is a 501(c)(3) non-profit organization whose initiatives include ToFightCancer and Pancreatica. Recently, a seasoned specialist told us that we had the highest social good to donation ratio that they had ever seen in any non-profit. Our mission is to promote awareness, increase education, and further pancreatic cancer research, especially programs aimed at:
• Promoting education
• Community awareness
• Providing the most current medical research results for patients, physicians and researchers
All donations are tax-deductible.
We put all donations to serious use toward the mission of fighting pancreatic cancer. Less than 8% of donated funds are used for management expenses.
When participating to help fight pancreatic cancer, you work to raise money by participating in a walk or run, honoring a loved one, or choosing any creative activity that you like! There are so many ways to support pancreatic cancer, and the choice is yours!
The Pancreatica.org initiative is dedicated to confronting pancreatic cancer and creating optimal treatment strategies for pancreatic cancer patients and their loved ones. This web-based resource is a key clearing house containing unique educational understanding for patients, their caregivers, physicians and researchers. For example, it includes a Medical Literature section that displays an impressive concentration of information on published scientific articles.
Our aim is to present impartial knowledge about pancreatic cancer whereby interested parties can access the range of existing treatment options, to aid patient/doctor partnerships, and thus help medical teams optimize personal treatment strategies.
Receiving a diagnosis of pancreatic cancer is serious news. For some, conventional surgical and /or medical therapy is the best option. For many of those with more advanced disease, putting one’s affairs in order and seeking that medical attention which will help insure physical and emotional comfort, is the correct and most responsible decision. But for others who wish to fight, it is important to know that there are options. There have never been this many options. The odds, depending on the type and extent of the tumor, may not be great, but fighting these odds may increase survival and may even provide an increased sense of well-being. And some people find meaning in the fight itself. We trust that Pancreatica.org provides the kind of information that is necessary to begin the search for personalized optimal treatment strategies for pancreatic cancer.
• Giving free access to the world’s top medical resource
• Providing help for optimizing personal treatment strategies to live longer
• This is a massive undertaking supported entirely by your tax-free donations… Learn More
• Currently, no standard marker exists to diagnose the disease earlier
• Our aim is to support the development of a marker for early diagnosis and screening
• If the disease is found even a year earlier, outcomes will begin to immediately improve…Learn More
A Look at Pancreatic Cancer
The pancreas is a small spongy organ that lies under the curvature of the stomach and deep within the abdomen. The pancreas does two main things: produces enzymes that are useful for the digestion of food AND secretes hormones (like insulin and glucagon) that help maintain and regulate body sugar levels. Cancer is now the most common cause of death in the, and the fourth most common cause of cancer mortality. It is the most aggressive of the major cancers. Although there are exceptions, usually patients only have a few months to live after they are diagnosed with pancreatic cancer. Typically, the symptoms of adenocarcinoma of the pancreas are vague — and include malaise, fatigue, loss-of-appetite, weight loss, abdominal discomfort and nausea. Also, the most common presenting physical sign of pancreatic cancer, that of jaundice, is typically shown late in the disease progression.
Pancreatic cancer is the least funded cancer in terms of research. Despite causing enormous mortality, pancreatic cancer receives (on a mortality basis) much less funding for research than most of the other major cancers. Currently, there is no molecular marker or genetic screening tool to aid in the earlier diagnosis or screening of pancreatic cancer. The treatment results would improve significantly if this cancer could be diagnosed at an earlier stage. Pancreatic cancer will cause more than 40,000 deaths in the U.S. this year OR more than 1% of all U.S. mortality. It also causes twice this number of deaths annually in Europe. Despite the huge toll, people often do not understand the full magnitude of this disease.
Pancreatic cancer is more common in African-Americans. It is strongly associated with smoking and likely associated with diets rich in saturated fats. There appears to be a mild correlation between the onset of diabetes and pancreatic cancer, but it is not entirely clear if this is a cause or an effect of the cancer. There does not appear to be a strong correlation between pancreatic cancer and the moderate drinking of alcohol or of coffee (though these have been past issues of some controversy). In a small percentage of cases, pancreatic cancer stems from a familial genetic predisposition.